{"pmid":32501018,"title":"Primary healthcare practitioners and patient blood management in Africa in the time of coronavirus disease 2019: Safeguarding the blood supply.","text":["Primary healthcare practitioners and patient blood management in Africa in the time of coronavirus disease 2019: Safeguarding the blood supply.","The coronavirus disease 2019 (COVID-19) pandemic has highlighted various weaknesses in global healthcare services. The blood supply in Africa is a critical element of the healthcare service that may be significantly affected by the pandemic. By implementing principles of patient blood management, primary healthcare practitioners may play an important role in the resilience of the blood supply during the COVID-19 pandemic.","Afr J Prim Health Care Fam Med","Barrett, Claire L","32501018"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic has highlighted various weaknesses in global healthcare services. The blood supply in Africa is a critical element of the healthcare service that may be significantly affected by the pandemic. By implementing principles of patient blood management, primary healthcare practitioners may play an important role in the resilience of the blood supply during the COVID-19 pandemic."],"journal":"Afr J Prim Health Care Fam Med","authors":["Barrett, Claire L"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501018","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.4102/phcfm.v12i1.2457","keywords":["africa","blood supply","covid-19","patient blood management","resilience","transfusion"],"topics":["Prevention"],"weight":1,"_version_":1668890966373695488,"score":9.490897,"similar":[{"pmid":32339260,"title":"Patient blood management during the COVID-19 pandemic: a narrative review.","text":["Patient blood management during the COVID-19 pandemic: a narrative review.","As COVID-19 disease escalates globally, optimising patient outcome during this catastrophic healthcare crisis is the number one priority. The principles of patient blood management are fundamental strategies to improve patient outcomes and should be given high priority in this crisis situation. The aim of this expert review is to provide clinicians and healthcare authorities with information regarding how to apply established principles of patient blood management during the COVID-19 pandemic. In particular, this review considers the impact of the COVID-19 pandemic on blood supply and specifies important aspects of donor management. We discuss how preventative and control measures implemented during the COVID-19 crisis could affect the prevalence of anaemia, and highlight issues regarding the diagnosis and treatment of anaemia in patients requiring elective or emergency surgery. In addition, we review aspects related to patient blood management of critically ill patients with known or suspected COVID-19, and discuss important alterations of the coagulation system in patients hospitalised due to COVID-19. Finally, we address special considerations pertaining to supply-demand and cost-benefit issues of patient blood management during the COVID-19 pandemic.","Anaesthesia","Baron, D M","Franchini, M","Goobie, S M","Javidroozi, M","Klein, A A","Lasocki, S","Liumbruno, G M","Munoz, M","Shander, A","Spahn, D R","Zacharowski, K","Meybohm, P","32339260"],"abstract":["As COVID-19 disease escalates globally, optimising patient outcome during this catastrophic healthcare crisis is the number one priority. The principles of patient blood management are fundamental strategies to improve patient outcomes and should be given high priority in this crisis situation. The aim of this expert review is to provide clinicians and healthcare authorities with information regarding how to apply established principles of patient blood management during the COVID-19 pandemic. In particular, this review considers the impact of the COVID-19 pandemic on blood supply and specifies important aspects of donor management. We discuss how preventative and control measures implemented during the COVID-19 crisis could affect the prevalence of anaemia, and highlight issues regarding the diagnosis and treatment of anaemia in patients requiring elective or emergency surgery. In addition, we review aspects related to patient blood management of critically ill patients with known or suspected COVID-19, and discuss important alterations of the coagulation system in patients hospitalised due to COVID-19. Finally, we address special considerations pertaining to supply-demand and cost-benefit issues of patient blood management during the COVID-19 pandemic."],"journal":"Anaesthesia","authors":["Baron, D M","Franchini, M","Goobie, S M","Javidroozi, M","Klein, A A","Lasocki, S","Liumbruno, G M","Munoz, M","Shander, A","Spahn, D R","Zacharowski, K","Meybohm, P"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339260","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/anae.15095","keywords":["covid-19","anaemia","coagulation","coronavirus","patient blood management"],"topics":["Prevention"],"weight":1,"_version_":1666138494252089345,"score":264.9241},{"pmid":32436251,"title":"Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee.","text":["Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee.","The emerging COVID-19 pandemic has overwhelmed healthcare resources worldwide, and for transfusion services this could potentially result in rapid imbalance between supply and demand due to a severe shortage of blood donors. This may result in insufficient blood components to meet every patient's needs resulting in difficult decisions about which patients with major bleeding do and do not receive active transfusion support. This document, which was prepared on behalf of the National Blood Transfusion Committee in England, provides a framework and triage tool to guide the allocation of blood for patients with massive haemorrhage during severe blood shortage. Its goal is to provide blood transfusions in an ethical, fair, and transparent way to ensure that the greatest number of life years are saved. It is based on an evidence- and ethics-based Canadian framework, and would become operational where demand for blood greatly exceeds supply, and where all measures to manage supply and demand have been exhausted. The guidance complements existing national shortage plans for red cells and platelets.","Br J Haematol","Doughty, Heidi","Green, Laura","Callum, Jeannie","Murphy, Michael F","32436251"],"abstract":["The emerging COVID-19 pandemic has overwhelmed healthcare resources worldwide, and for transfusion services this could potentially result in rapid imbalance between supply and demand due to a severe shortage of blood donors. This may result in insufficient blood components to meet every patient's needs resulting in difficult decisions about which patients with major bleeding do and do not receive active transfusion support. This document, which was prepared on behalf of the National Blood Transfusion Committee in England, provides a framework and triage tool to guide the allocation of blood for patients with massive haemorrhage during severe blood shortage. Its goal is to provide blood transfusions in an ethical, fair, and transparent way to ensure that the greatest number of life years are saved. It is based on an evidence- and ethics-based Canadian framework, and would become operational where demand for blood greatly exceeds supply, and where all measures to manage supply and demand have been exhausted. The guidance complements existing national shortage plans for red cells and platelets."],"journal":"Br J Haematol","authors":["Doughty, Heidi","Green, Laura","Callum, Jeannie","Murphy, Michael F"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436251","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/bjh.16736","keywords":["national blood transfusion committee","blood shortage","guidance","massive bleeding","triage"],"locations":["England","Canadian"],"countries":["Canada","United Kingdom"],"countries_codes":["CAN|Canada","GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1667521393845075968,"score":177.58127},{"pmid":32243296,"pmcid":"PMC7173035","title":"The Essential Role of Patient Blood Management in a Pandemic: A Call for Action.","text":["The Essential Role of Patient Blood Management in a Pandemic: A Call for Action.","The World Health Organization (WHO) has declared Coronavirus Disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. Global health care now faces unprecedented challenges with widespread and rapid human-to-human transmission of SARS-CoV-2 and high morbidity and mortality with COVID-19 worldwide. Across the world, the medical care is hampered by a critical shortage of not only hand sanitizers, personal protective equipment, ventilators and hospital beds, but also impediments to the blood supply. Blood donation centers in many areas around the globe have mostly closed. Donors, practicing social distancing, some either with illness or undergoing self-quarantine, are quickly diminishing. Drastic public health initiatives have focused on containment and \"flattening the curve\" while invaluable resources are being depleted. In some countries, the point is reached at which demand for such resources, including donor blood outstrips supply. Questions as to the safety of blood persist. Although it does not appear very likely that the virus can be transmitted through allogeneic blood transfusion, this still remains to be fully determined. As options dwindle, we must enact regional and national shortage plans worldwide, and more vitally disseminate the knowledge of and immediately implement Patient Blood Management (PBM). PBM is an evidence-based bundle of care to optimize medical and surgical patient outcomes by clinically managing and preserving a patient's own blood. This multinational and diverse group of authors issue this \"Call to Action\" underscoring \"The Essential Role of Patient Blood Management in the Management of Pandemics\" and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches.","Anesth Analg","Shander, Aryeh","Goobie, Susan Marie","Warner, Matthew A","Aapro, Matti","Bisbe, Elvira","Perez-Calatayud, Angel A","Callum, Jeannie","Cushing, Melissa M","Dyer, Wayne B","Erhard, Jochen","Faraoni, David","Farmer, Shannon","Fedorova, Tatyana","Frank, Steven M","Froessler, Bernd","Gombotz, Hans","Gross, Irwin","Guinn, Nicole R","Haas, Thorsten","Hamdorf, Jeffrey","Isbister, James P","Javidroozi, Mazyar","Ji, Hongwen","Kim, Young-Woo","Kor, Daryl J","Kurz, Johann","Lasocki, Sigismond","Leahy, Michael F","Lee, Cheuk-Kwong","Lee, Jeong Jae","Louw, Vernon","Meier, Jens","Mezzacasa, Anna","Munoz, Manuel","Ozawa, Sherri","Pavesi, Marco","Shander, Nina","Spahn, Donat R","Spiess, Bruce D","Thomson, Jackie","Trentino, Kevin","Zenger, Christoph","Hofmann, Axel","32243296"],"abstract":["The World Health Organization (WHO) has declared Coronavirus Disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. Global health care now faces unprecedented challenges with widespread and rapid human-to-human transmission of SARS-CoV-2 and high morbidity and mortality with COVID-19 worldwide. Across the world, the medical care is hampered by a critical shortage of not only hand sanitizers, personal protective equipment, ventilators and hospital beds, but also impediments to the blood supply. Blood donation centers in many areas around the globe have mostly closed. Donors, practicing social distancing, some either with illness or undergoing self-quarantine, are quickly diminishing. Drastic public health initiatives have focused on containment and \"flattening the curve\" while invaluable resources are being depleted. In some countries, the point is reached at which demand for such resources, including donor blood outstrips supply. Questions as to the safety of blood persist. Although it does not appear very likely that the virus can be transmitted through allogeneic blood transfusion, this still remains to be fully determined. As options dwindle, we must enact regional and national shortage plans worldwide, and more vitally disseminate the knowledge of and immediately implement Patient Blood Management (PBM). PBM is an evidence-based bundle of care to optimize medical and surgical patient outcomes by clinically managing and preserving a patient's own blood. This multinational and diverse group of authors issue this \"Call to Action\" underscoring \"The Essential Role of Patient Blood Management in the Management of Pandemics\" and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches."],"journal":"Anesth Analg","authors":["Shander, Aryeh","Goobie, Susan Marie","Warner, Matthew A","Aapro, Matti","Bisbe, Elvira","Perez-Calatayud, Angel A","Callum, Jeannie","Cushing, Melissa M","Dyer, Wayne B","Erhard, Jochen","Faraoni, David","Farmer, Shannon","Fedorova, Tatyana","Frank, Steven M","Froessler, Bernd","Gombotz, Hans","Gross, Irwin","Guinn, Nicole R","Haas, Thorsten","Hamdorf, Jeffrey","Isbister, James P","Javidroozi, Mazyar","Ji, Hongwen","Kim, Young-Woo","Kor, Daryl J","Kurz, Johann","Lasocki, Sigismond","Leahy, Michael F","Lee, Cheuk-Kwong","Lee, Jeong Jae","Louw, Vernon","Meier, Jens","Mezzacasa, Anna","Munoz, Manuel","Ozawa, Sherri","Pavesi, Marco","Shander, Nina","Spahn, Donat R","Spiess, Bruce D","Thomson, Jackie","Trentino, Kevin","Zenger, Christoph","Hofmann, Axel"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243296","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1213/ANE.0000000000004844","topics":["Prevention"],"weight":1,"_version_":1666138492137111553,"score":169.97343},{"pmid":32464700,"title":"Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety.","text":["Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety.","Most high-income countries are aggressively engaged in the collection and research evaluation of convalescent plasma as a specific passive immunotherapy for treatment of COVID-19. Preliminary clinical data fully support such initiatives. Outbreaks of COVID-19 are now dramatically affecting LMIC, which have restricted capability for ensuring organized and controlled collection of safe blood and plasma collection due to fragmented blood systems with limited oversight, infrastructure, equipment, and trained personnel. Nevertheless, there is an urgent effort in LMIC to provide COVID-19 convalescent plasma as a potentially effective therapy that can be produced locally. The Working Party on Global Blood Safety of the International Society of Blood Transfusion has published \"Points to consider in the preparation and transfusion of COVID-19 convalescent plasma in low- and middle- income countries\". The purpose of this commentary is to provide an urgent general frame of ethical and technical recommendations on the use of convalescent plasma to treat patients affected by the SARS-CoV-2 virus in LMIC. Key ethical, quality, and safety guidance for the selection of donors, the collection and processing of blood, and the transfusion of COVID-19 convalescent plasma should be followed. Governments should be reminded that an adequate supply of quality and safe blood components for transfusion is essential to meet the primary healthcare needs of the population. The response to the COVID-19 epidemic highlights the importance of capacity building for an organized and sustainable national blood system while steps are taken to provide appropriately collected, tested and processed COVID-19 convalescent plasma for investigational clinical use.","Vox Sang","Epstein, Jay","Smid, Martin","Wendel, Silvano","Somuah, Daniel","Burnouf, Thierry","32464700"],"abstract":["Most high-income countries are aggressively engaged in the collection and research evaluation of convalescent plasma as a specific passive immunotherapy for treatment of COVID-19. Preliminary clinical data fully support such initiatives. Outbreaks of COVID-19 are now dramatically affecting LMIC, which have restricted capability for ensuring organized and controlled collection of safe blood and plasma collection due to fragmented blood systems with limited oversight, infrastructure, equipment, and trained personnel. Nevertheless, there is an urgent effort in LMIC to provide COVID-19 convalescent plasma as a potentially effective therapy that can be produced locally. The Working Party on Global Blood Safety of the International Society of Blood Transfusion has published \"Points to consider in the preparation and transfusion of COVID-19 convalescent plasma in low- and middle- income countries\". The purpose of this commentary is to provide an urgent general frame of ethical and technical recommendations on the use of convalescent plasma to treat patients affected by the SARS-CoV-2 virus in LMIC. Key ethical, quality, and safety guidance for the selection of donors, the collection and processing of blood, and the transfusion of COVID-19 convalescent plasma should be followed. Governments should be reminded that an adequate supply of quality and safe blood components for transfusion is essential to meet the primary healthcare needs of the population. The response to the COVID-19 epidemic highlights the importance of capacity building for an organized and sustainable national blood system while steps are taken to provide appropriately collected, tested and processed COVID-19 convalescent plasma for investigational clinical use."],"journal":"Vox Sang","authors":["Epstein, Jay","Smid, Martin","Wendel, Silvano","Somuah, Daniel","Burnouf, Thierry"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464700","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/vox.12964","keywords":["covid-19","lmic","convalescent plasma","coronavirus","transfusion"],"topics":["Prevention"],"weight":1,"_version_":1668079521337704449,"score":165.03471},{"pmid":32386966,"title":"The blood supply management amid the COVID-19 outbreak.","text":["The blood supply management amid the COVID-19 outbreak.","Due to the government's early intervention such as mass lockdown and curtailment strategies towards mass gatherings, amid the COVID-19 outbreak, the organization of the voluntary blood donation camps have been suspended. It's most significant impact on the blood community has been a dramatic decrease in the number of blood donors. Therefore, our blood stock has almost dried up and put our inventory in a state of jeopardy. Additionally, all the elective surgeries and non-urgent clinical interventions have also been deferred during this time. This has led to a drop in the blood collection, demand as well as the issue at our blood center. With this backdrop, we intended to assess the effect of this mass lockdown on our blood supply management, particularly in two phases [phase-I prior to the outbreak] and phase-II [during the outbreak]. Transitioning back to the normal conditions would most likely depend on the extent and the time duration of this pandemic and associated behavioural change, which is foreseen to remain in effect well beyond the original estimates.","Transfus Clin Biol","Raturi, M","Kusum, A","32386966"],"abstract":["Due to the government's early intervention such as mass lockdown and curtailment strategies towards mass gatherings, amid the COVID-19 outbreak, the organization of the voluntary blood donation camps have been suspended. It's most significant impact on the blood community has been a dramatic decrease in the number of blood donors. Therefore, our blood stock has almost dried up and put our inventory in a state of jeopardy. Additionally, all the elective surgeries and non-urgent clinical interventions have also been deferred during this time. This has led to a drop in the blood collection, demand as well as the issue at our blood center. With this backdrop, we intended to assess the effect of this mass lockdown on our blood supply management, particularly in two phases [phase-I prior to the outbreak] and phase-II [during the outbreak]. Transitioning back to the normal conditions would most likely depend on the extent and the time duration of this pandemic and associated behavioural change, which is foreseen to remain in effect well beyond the original estimates."],"journal":"Transfus Clin Biol","authors":["Raturi, M","Kusum, A"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32386966","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.tracli.2020.04.002","keywords":["blood management","blood transfusion services","coronavirus infection","pandemic","voluntary blood donation"],"topics":["Prevention"],"weight":1,"_version_":1666428892714369024,"score":160.48927}]}